skip to Main Content

About

Measuring severity in functional GI disorders (FGIDs) is extremely important since it can guide diagnostic evaluation, risk assessment, and treatment decisions. However, there has been a lack of consensus regarding severity in irritable bowel syndrome (IBS) and other FGIDs. In late 2005, the Rome Foundation assembled a working group to develop guidelines for severity assessment in FGID. This committee is comprised of members with different areas of expertise but with a mutual interest in severity and/or health outcomes assessment. The committee produced a report that has been published in the The American Journal of Gastroenterology.

Publication

Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report
Drossman, D. A., Chang, L., Bellamy, N., Gallo-Torres, H. E., Lembo, A., Mearin, F., Norton, N., Whorwell, P.
Am J Gastroenterol, 106(10), 1749-1759; quiz 1760
Abstract

Members of the Working Team

Chair

Douglas A. Drossman, MD
UNC Center for Functional GI and Motility Disorders
Chapel Hill, North Carolina, USA

Co-Chair

Lin Chang, MD
UCLA
Center for Neurobiology of Stress
Los Angeles,California, USA

Nicholas Bellamy, DSc
Centre of National Research on Disability and Rehabilitation Medicine
The University of Queensland
Brisbane, Queensland, Australia

Hugo Gallo-Torres, MD
Food and Drug Administration
Division of Gastrointestinal and Coagulation Drug Products
Bethesda, Maryland, USA

Anthony Lembo, MD
Beth Israel Deaconess Medical Center
Harvard University
Cambridge, Massachusetts, USA

Fermín Mearin, MD
Institute of Functional and Motor Digestive Disorders
Centro Médico Teknon
Barcelona, Spain

Nancy Norton
International Foundation for Functional Gastrointestinal Disorders
Milwaukee, Wisconsin, USA

Peter Whorwell, MD, FRCP
Gastroenterology Department
Wythenshawe Hospital
Manchester University, Manchester, UK

Back To Top